참고문헌
- Wharton RH, Loechner KJ. Genetic and clinical advances in Prader-Willi syndrome. Curr Opin Pediatr 1996;8:618-24 https://doi.org/10.1097/00008480-199612000-00013
- Cassidy SB. Prader-Willi syndrome. J Med Genet 1997; 34:917-23 https://doi.org/10.1136/jmg.34.11.917
- Holm VA, Cassidy SB, Butler MG, Hanchett 1M, Greenswag LR, Whitman BY, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics 1993;91:398-402
- Butler MG, Meaney FJ. Standards for selected anthropometric measurements in Prader- Willi syndrome. Pediatrics 1991;88:853-60
- Bray GA, Dahms WT, Swerdloff RS, Fiser RH, Atkinson RL, Carrel RE. The Prader- Willi syndrome: a study of 40 patients and a review of the literature. Medicine (Baltimore) 1983;62:59-80 https://doi.org/10.1097/00005792-198303000-00001
- Brambilla P, Bosio L, Manzoni P, Pietrobelli A, Beccaria L, Chiumello G. Peculiar body composition in patients with Prader-Labhart-Willi syndrome. Am J Clin Nutr 1997;65: 1369-74 https://doi.org/10.1093/ajcn/65.5.1369
- Eiholzer U, Blum WF, Molinari L. Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader -Labhart-Willi syndrome. J Pediatr 1999;134:222-5 https://doi.org/10.1016/S0022-3476(99)70419-1
- Burman P, Ritzen EM, Lindgren AC. Endocrine dysfunction in Prader- Willi syndrome: a review with special reference to GH. Endocr Rev 2001;22:787-99 https://doi.org/10.1210/er.22.6.787
- Beccaria L, Benzi F, Sanzari A, Bosio L, Brambilla P, Chiumello G. Impairment of growth hormone responsiveness to growth hormone releasing hormone and pyridostigmine in patients affected by Prader-Labhardt-Willi syndrome. J Endocrinol Invest 1996;19:687-92 https://doi.org/10.1007/BF03349040
- Angulo M, Castro-Magana M, Mazur B, Canas JA, Vitollo PM, Sarrantonio M. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader- Willi syndrome. J Pediatr En- docrinol Metab 1996;9:393-400
- Corrias A, BelloneJ, Beccaria L, Bosio L, Trifiro G, Livieri C, et al. GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabe tology. J Endocrinol Invest 2000;23:84-9 https://doi.org/10.1007/BF03343684
- Grugni G, Guzzaloni G, Moro D, Bettio D, De Medici C, Morabito F. Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader- Willi syndrome. Clin Endocrinol (Oxf ) 1998;48:769-75 https://doi.org/10.1046/j.1365-2265.1998.00435.x
- Lindgren AC, Hagenas L, MullerJ, Blichfeldt S, Rosenborg M, Brismar T, et al. Growth hormone treatment of children with Prader- Willi syndrome affects linear growth and body composition favourably. Acta Paediatr 1998;87:28-31 https://doi.org/10.1080/08035259850157822
- Carrel AL, Allen DB. Effects of growth hormone on body composition and bone metabolism. Endocrine 2000;12:163-72 https://doi.org/10.1385/ENDO:12:2:163
- Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome: a -l-vear study. J Clin Endocrinol Metab 2002;87:1581-5 https://doi.org/10.1210/jc.87.4.1581
- Carrel AL, Myers SE, Whitman BY, Allen DB. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study. J Pediatr 1999;134:215-21 https://doi.org/10.1016/S0022-3476(99)70418-X
- Eiholzer U, Gisin R, Weinmann C, Kriemler S, Steinert H, Torresani T, et al. Treatment with human growth hormone in patients with Prader- Labhart- Willi syndrome reduces body fat and increases muscle mass and physical performance. Eur J Pediatr 1998;157:368-77
- Myers SE, Carrel AL, Whitman BY, Allen DB. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr 2000;137:42-9 https://doi.org/10.1067/mpd.2000.105369
- Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader- Willi syndrome. J Clin Endocrinol Metab 2003;88: 2206-12 https://doi.org/10.1210/jc.2002-021536
- Eiholzer U. Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res 2005; 63:33-9 https://doi.org/10.1159/000082745
- Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, et al. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol (Oxf ) 2006;65:178-85 https://doi.org/10.1111/j.1365-2265.2006.02570.x
- Crino A, Di Giorgio G, Manco M, Grugni G, Maggioni A. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome. Horm Res 2007;68:83-90 https://doi.org/10.1159/000100371
- L' Allemand D, Eiholzer U, Schlumpf M, Torresani T, Girard J. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with PraderWilli syndrome. Horm Res 2003;59:239-48 https://doi.org/10.1159/000070224
- Obata K, Sakazume S, Yoshino A, Murakami N, Sakuta R. Effects of 5 years growth hormone treatment in patients with Prader- Willi syndrome. J Pediatr Endocrinol Metab 2003;16:155-62
- Hoybye C. Five-years growth hormone (GH) treatment in adults with Prader- Willi syndrome. Acta Paediatr 2007;96: 410-3 https://doi.org/10.1111/j.1651-2227.2006.00051.x
- Shin HJ, Kim DH. Effects of Growth Hormone Therapy in Prader-Willi Syndrome. J Korean Soc Pediatr Endocrinol 2000;5:52-9
- Park JE, Lee SW, Song KE, Lee HS, Kim DJ, Chung YS, et al. Growth Hormone Treatment in Prader-Willi Syndrome. J Korean Soc Endocrinol 2006;21:40-6 https://doi.org/10.3803/jkes.2006.21.1.40
- Dieguez C, Page MD, Scanlon MF. Growth hormone neuro regulation and its alterations in disease states. Clin Endocrinol (Oxf) 1988;28:109-43 https://doi.org/10.1111/j.1365-2265.1988.tb01209.x
- Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 1984;311:1403-7 https://doi.org/10.1056/NEJM198411293112203
- Holm V A, Laurnen EL. Prader- Willi syndrome and scoliosis. Dev Med Child Neurol 1981;23:192-201 https://doi.org/10.1111/j.1469-8749.1981.tb02441.x
- Nagai T, Obata K, Ogata T, Murakami N, Katada Y, Yoshino A, et al. Growth hormone therapy and scoliosis in patients with Prader- Willi syndrome. Am J Med Genet A 2006;140:1623-7
- Angulo MA, Castro-Magana M, Lamerson M, Arguello R, Accacha S, Khan A. Final adult height in children with Prader- Willi syndrome with and without human growth hormone treatment. Am J Med Genet A 2007;143A:1456-61 https://doi.org/10.1002/ajmg.a.31824
- Richards A, Quaghebeur G, Clift S, Holland A, Dahlitz M, Parkes D. The upper airway and sleep apnoea in the Prader-Willi syndrome. Clin Otolaryngol Allied Sci 1994;19: 193-7 https://doi.org/10.1111/j.1365-2273.1994.tb01213.x
- Gerard JM, Garibaldi L, Myers SE, Aceto T Jr, Kotagal S, Gibbons VP, et al. Sleep apnea in patients receiving growth hormone. Clin Pediatr (Phila) 1997;36:321-6 https://doi.org/10.1177/000992289703600602
피인용 문헌
- Quality of Life in Prader-Willi Syndrome Patients vol.1, pp.2, 2015, https://doi.org/10.19125/jmrd.2015.1.2.60
- Beneficial Effects of Growth Hormone Treatment in Prader-Willi Syndrome vol.3, pp.2, 2008, https://doi.org/10.19125/jmrd.2017.3.2.41